Non-Hodgkin lymphoma is the fifth most common disease in the United States and worldwide infecting about 13,400 people. That’s about 37 cases every day. Raising awareness could help inform people of the risks of non-Hodgkin lymphoma by decreasing the amount of serum interleukin in your body, staying away from certain chemicals in your job or even at your own home, and decreasing the amount of people diagnosed or even killed.
Non-Hodgkin lymphoma patients with high levels of serum interleukin have a shorter survival than the average lymphoma patient. Some patients with Non-Hodgkin lymphoma and high amounts of serum vascular endothelial growth can also affect your survival time. Non-Hodgkin lymphoma is a type of cancer which develops in the lymphatic
Non-Hodgkin lymphoma patients with high levels of serum interleukin have a shorter survival than the average lymphoma patient. Some patients with Non-Hodgkin lymphoma and high amounts of serum vascular endothelial growth can also affect your survival time. Non-Hodgkin lymphoma is a type of cancer which develops in the lymphatic